Self-Tolerance Does Not Restrict the CD4+ T-Helper Response against the p53 Tumor Antigen

Tumorigenesis is frequently associated with mutation and overexpression of p53, which makes it an attractive target antigen for T cell-mediated immunotherapy of cancer. However, the magnitude and breadth of the p53-specific T-cell repertoire may be restricted due to the ubiquitous expression of wild...

Full description

Saved in:
Bibliographic Details
Published in:Cancer research (Chicago, Ill.) Ill.), 2008-02, Vol.68 (3), p.893-900
Main Authors: LAUWEN, Marjolein M, ZWAVELING, Sander, DE QUARTEL, Linda, FERREIRA MOTA, S. Carmela, GRASHORN, Janine A. C, MELIEF, Cornelis J. M, VAN DER BURG, Sjoerd H, OFFRINGA, Rienk
Format: Article
Language:English
Subjects:
Amino Acid Sequence
Animals
Antibody Affinity
Antigen Presentation
Antineoplastic agents
Biological and medical sciences
Cancer Vaccines - immunology
Cross Reactions
Epitopes, T-Lymphocyte
Female
Immunotherapy, Adoptive
Medical sciences
Mice
Mice, Inbred C57BL
Mice, Knockout
Molecular Sequence Data
Neoplasms, Experimental - immunology
Neoplasms, Experimental - therapy
Pharmacology. Drug treatments
Self Tolerance - immunology
T-Lymphocytes, Helper-Inducer - immunology
Tumor Suppressor Protein p53 - immunology
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Tumorigenesis is frequently associated with mutation and overexpression of p53, which makes it an attractive target antigen for T cell-mediated immunotherapy of cancer. However, the magnitude and breadth of the p53-specific T-cell repertoire may be restricted due to the ubiquitous expression of wild-type p53 in normal somatic tissues. In view of the importance of the CD4+ T-helper cell responses in effective antitumor immunity, we have analyzed and compared the p53-specific reactivity of this T cell subset in p53+/+ and p53-/- C57Bl/6 mice. This response was found to be directed against the same three immunodominant epitopes in both mouse types. Fine-specificity, magnitude, and avidity were not affected by self-tolerance. Immunization of p53-/- and p53+/+ mice with synthetic peptide vaccines comprising the identified epitopes induced equal levels of Th1 immunity. Our findings imply that the p53-specific CD4+ T-cell repertoire is not restricted by self-tolerance and is fully available for the targeting of cancer.
ISSN:0008-5472
1538-7445
DOI:10.1158/0008-5472.CAN-07-3166